<DOC>
	<DOCNO>NCT01582477</DOCNO>
	<brief_summary>The purpose study assess safety efficacy EXPAREL administer via infiltration transversus abdominis plane ( TAP ) prolong postsurgical analgesia men undergo robot-assisted laparoscopic prostatectomy .</brief_summary>
	<brief_title>TAP-patients With Robotic Assisted Lap Prostatectomy</brief_title>
	<detailed_description>Assess safety efficacy EXPAREL administer via infiltration transversus abdominis plane ( TAP ) provide prolonged postsurgical analgesia men undergo robot-assisted laparoscopic prostatectomy . The primary endpoint duration abdominal analgesia infiltration TAP measure time subject 's first postsurgical opioid administration .</detailed_description>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>male subject , age 1875 . American Society Anesthesiology ( ASA ) physical status 13 . Undergoing robotassisted laparoscopic prostatectomy perform single surgeon ( Ingolf Tuerk , MD ) . Subjects must physically mentally able participate study complete study assessment . Subjects must able give fully inform consent participate study demonstrate good understanding risk benefit TAP infiltration . Demonstrated hypersensitivity idiosyncratic reaction amidetype local anesthetic . Inability tolerate oxycodone acetaminophen ( e.g . Percocet ) . Any subject whose anatomy surgical procedure opinion Investigator might preclude potential successful performance TAP . Any subject opinion Investigator might harm poor candidate participation study . Subjects receive investigational drug within 30 day prior study drug administration plan administration another investigational product procedure participation study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>TAP , robot-assisted prostatectomy</keyword>
</DOC>